@FollicleThought @KikilaKikili https://t.co/nVXJtZepZU
"Heqirui Medicine announced that the first new monoclonal antibody drug HMI-115 has been approved for the phase II clinical trial in China for the treatment of androgenetic alopecia"
@HairDAO_ It doesn't sound that way on Folliclethought: "The second cohort of treated subjects received a high dose of AR68, 5mg once per week..the treated group showed an average increase of 7.7 hairs per cm2...high dose AR68 performed 83% as efficacious as finasteride."